Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Adlai Nortye, a clinical-stage biotechnology company listed on NASDAQ, has appointed Christopher Liu, PharmD, an equity research veteran specializing in biotechnology and oncology, as its new Head of Investor Relations and Public Relations. This strategic hire aims to strengthen engagement with the global investment community and improve the commun…
Beamr Imaging Ltd. announced a three-year renewal of its license agreement with a major global streaming platform extending through 2029, resulting in an expected 50% increase in fiscal year 2026 revenues to approximately $4.5 million. The company highlights sustainable demand for its video optimization technology and anticipates continued growth i…
Ceribell, Inc. has received FDA 510(k) clearance for new software updates to its Ceribell System that simplify interpretation of EEG data. These updates include features such as Alpha-Delta Ratio and Relative Alpha Trending, Burst Suppression monitoring, and Amplitude-Integrated EEG analysis, enabling faster and easier brain monitoring in critical …
Harrow, Inc. announced that fifteen scientific abstracts highlighting clinical data from its ophthalmic product portfolio will be presented at the 2026 American Academy of Optometry and American Academy of Ophthalmology meetings. The research spans multiple eye conditions, including dry eye disease, vernal keratoconjunctivitis, ocular inflammation,…
Sono-Tek Corporation announced it received three purchase orders totaling $7.19 million from an existing clean energy sector customer, marking the largest order in the company's history. These orders consist of 10 production-scale ultrasonic coating systems to be delivered primarily in fiscal 2028, significantly increasing revenue visibility. Along…
Kailera Therapeutics announced the completion of enrollment in its KaiNETIC global Phase 3 clinical program evaluating ribupatide injection, a dual GLP-1/GIP receptor agonist, for obesity treatment. The program includes three trials with topline data expected by mid-2028. Ribupatide aims to provide a once-weekly injectable treatment addressing unme…
Tilray Brands’ 10 Barrel Brewing introduces the Salty Sips Blackberry Refresher, a low-sugar, vodka-based ready-to-drink cocktail featuring real blackberry juice and sea salt. Following the successful launch of the Watermelon Refresher, this new flavor aims to cater to consumers seeking flavorful, balanced, and easy-drinking options. Initially avai…
Satellos Bioscience Inc. announced the successful completion of enrollment for the BASECAMP Phase 2 clinical trial evaluating their oral small molecule drug candidate forazapadin for treating Duchenne muscular dystrophy (DMD) in ambulatory boys aged 7 to 10. The trial, conducted globally across multiple sites, will assess safety, tolerability, and …
FactSet reported its fourth quarter and full fiscal 2026 financial results, highlighting a 7.0% increase in organic Annual Subscription Value (ASV), 6.7% revenue growth, and robust AI solution adoption which more than doubled year-over-year. The company maintained strong subscription retention and returned significant capital to shareholders throug…
GlobalFoundries announced the date for its third quarter 2026 financial results conference call, which will be held on November 4, 2026. The company highlighted its role as a leading manufacturer of semiconductors powering AI and various high-growth sectors. The call aims to provide insights into the company’s financial performance and operational …
Nexera Technologies’ majority-owned subsidiary Fort Technology has acquired a 50.1% interest in Logia USA, which holds an exclusive U.S. license for automated fuel-integrity systems developed by Logia Israel. This acquisition positions Fort to commercialize fuel maintenance solutions for standby generators in the growing U.S. data center market, pr…
Alamos Gold Inc., a Canadian-based intermediate gold producer listed on both the TSX and NYSE, plans to release its third quarter 2026 financial results after market close on October 28, 2026, followed by a management conference call on October 29, 2026. The company operates multiple mining sites in North America and continues to develop growth pro…
ANI Pharmaceuticals announced the presentation of new data from its Phase 4 SYNCHRONICITY trial on Fluocinolone Acetonide Intravitreal Implant for chronic non-infectious uveitis at the American Academy of Ophthalmology 2026 meeting. The data include six-month topline results and post-hoc analyses from the NEW DAY trial for diabetic macular edema. T…
Descartes Systems Group announced that it will showcase cutting-edge AI and logistics technology innovations designed to streamline supply chain operations at its 2026 Innovation Forum in Chicago. The technologies include AI-driven transportation management, fleet performance optimization, global trade intelligence, and ecommerce operations enhance…
Seanergy Maritime trades at a modest $355M market cap with a P/E of 5.7 and a 3.5% yield. The company’s Capesize-heavy fleet, shareholder-friendly payout, and a shallow float make the stock an asymmetric risk-reward. We rate SHIP Strong Buy and lay out an entry at $16.61, stop at $13.50 and a $24.00 target.
Zoetis is trading near its 52-week low after a string of execution concerns and legal headlines. With a market cap near $29B, EV/EBITDA ~9.0 and free cash flow of $2.37B, the stock offers a compelling risk/reward if you buy with discipline. This trade idea lays out an actionable entry at $70.50, a stop at $63.00, and a long-term target of $110.00, …
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company (Nasdaq: SGMT), announced it priced an underwritten offering of Series A common stock and pre-funded warrants, raising approximately $115 million before expenses. The company plans to use the proceeds to fund a Phase 3 clinical trial for denifanstat in acne, support pre-launch act…
Rackspace (RXT) is being punished largely for GAAP losses and litigation noise tied to an AI strategy disclosure. The company still generates positive free cash flow ($41M), trades at a modest price-to-sales of 0.37 and has an enterprise-value-to-sales of 1.51. For traders who can tolerate headline risk, a mid-term swing long aims to capture a sent…
Advanced Micro Devices trades near $608 with a stretched valuation (roughly 155x earnings and 24x sales), but accelerating AI demand, new product wins and the recent World Labs acquisition preserve upside. This is a tactical mid-term long: enter on current strength or small weakness, use a protective stop below $550, and target $680 within 45 tradi…
Mizuho Financial (MFG) looks attractive after recent Bank of Japan tightening and management's investor day narrative. The stock trades near $11.07 with a reasonable P/E of 15.2 and PB of 1.9, a dividend yield of ~1.26%, and a market cap around $135.8B. We lay out a long trade with an entry at $11.00, a stop at $10.20 and a $12.50 target over a 180…
Beam Global announced it will present its advanced battery technologies targeting high-power applications such as AI data centers and electric vertical takeoff and landing (eVTOL) aircraft at The Battery Show North America. The company highlighted its proprietary thermal management innovations designed to handle extreme power fluctuations and batte…
Cal-Maine Foods, the largest U.S. egg producer, reported a 41.5% drop in net sales and a net loss of $58.6 million in Q1 fiscal 2027 compared to a profit in the prior year. The decline was driven by a substantial fall in conventional shell egg prices due to market oversupply, despite stable volume. Specialty shell eggs and Prepared Foods now repres…
VisionWave Holdings, Inc., a US-based defense technology company, announces an expanded international demonstration program for its autonomous ground, aerial, and sensing technologies, including the VARAN unmanned ground vehicle. These demonstrations across North America, Europe, and Asia aim to engage prospective defense customers and partners for…
Sagimet Biosciences announced positive 52-week data from Ascletis' Phase 3 open-label extension trial of denifanstat, an oral FASN inhibitor for moderate to severe acne vulgaris. The results demonstrated sustained efficacy with a 57% treatment success rate and significant reduction in lesion counts, while maintaining a favorable safety profile. Sag…
Sezzle's recent results show outsized subscriber and revenue growth with durable marketing ROI and improving unit economics. The market is pricing in caution after management signaled a marketing pullback; that creates a tactical opportunity to buy growth at a mid-teens multiple to durable free cash flow. This trade targets a return to re-rating if…
